Chicago Equity Partners LLC lessened its holdings in shares of Phibro Animal Health Corp (NASDAQ:PAHC) by 26.6% during the 4th quarter, HoldingsChannel reports. The fund owned 24,515 shares of the company’s stock after selling 8,900 shares during the period. Chicago Equity Partners LLC’s holdings in Phibro Animal Health were worth $821,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also modified their holdings of the company. Prudential Financial Inc. raised its position in shares of Phibro Animal Health by 59.0% during the 3rd quarter. Prudential Financial Inc. now owns 141,760 shares of the company’s stock worth $5,253,000 after acquiring an additional 52,590 shares in the last quarter. Janus Henderson Group PLC acquired a new stake in shares of Phibro Animal Health during the 2nd quarter worth about $6,353,000. Magnetar Financial LLC acquired a new stake in shares of Phibro Animal Health during the 3rd quarter worth about $605,000. California Public Employees Retirement System raised its position in shares of Phibro Animal Health by 9.5% during the 3rd quarter. California Public Employees Retirement System now owns 44,994 shares of the company’s stock worth $1,667,000 after acquiring an additional 3,894 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its position in shares of Phibro Animal Health by 5.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 416,001 shares of the company’s stock worth $15,413,000 after acquiring an additional 19,994 shares in the last quarter. 48.31% of the stock is currently owned by institutional investors and hedge funds.
Several brokerages have recently weighed in on PAHC. Zacks Investment Research raised Phibro Animal Health from a “hold” rating to a “buy” rating and set a $41.00 target price on the stock in a research report on Thursday. Morgan Stanley lifted their price target on Phibro Animal Health from $30.00 to $36.00 and gave the stock an “underweight” rating in a research report on Wednesday. Credit Suisse Group lifted their price target on Phibro Animal Health from $37.00 to $39.00 and gave the stock a “neutral” rating in a research report on Tuesday. BidaskClub lowered Phibro Animal Health from a “sell” rating to a “strong sell” rating in a research report on Friday, January 26th. Finally, Piper Jaffray Companies reaffirmed a “buy” rating and set a $42.00 price target on shares of Phibro Animal Health in a research report on Friday, November 10th. Three equities research analysts have rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $38.20.
Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Monday, February 5th. The company reported $0.44 EPS for the quarter, topping the consensus estimate of $0.38 by $0.06. The company had revenue of $205.90 million for the quarter, compared to analyst estimates of $194.90 million. Phibro Animal Health had a return on equity of 40.49% and a net margin of 7.90%. The firm’s revenue was up 7.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.39 earnings per share. equities analysts expect that Phibro Animal Health Corp will post 1.65 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 28th. Shareholders of record on Wednesday, March 7th will be given a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a yield of 1.13%. The ex-dividend date of this dividend is Tuesday, March 6th. Phibro Animal Health’s dividend payout ratio (DPR) is 26.14%.
About Phibro Animal Health
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corp (NASDAQ:PAHC).
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.